Patent application number | Description | Published |
20080229608 | Method and Device for Drying Painted Vehicle Bodies - The invention relates to a method and a device for drying objects ( | 09-25-2008 |
20100326832 | Immersion Treatment System - The invention relates to an immersion treatment system, particularly an electrophoretic immersion coating system, comprising at least one immersion basin in a known manner that can be filled with a treatment fluid. A transport system guides the objects to be coated to the immersion basin, into the interior of the immersion basin, out of the immersion basin, and away therefrom. It comprises at least one transport car whereon a vertically displaceable carriage is disposed. A component defining a rotary axis is supported on the same, supporting a mounting device for the object to be treated. A motion sequence for the object can be achieved in said manner, comprising a superposition of a horizontal linear motion, a vertical linear motion, and a rotary motion about the rotary axis. | 12-30-2010 |
20130032089 | METHOD AND DEVICE FOR ELECTROSTATICALLY SEPARATING OVERSPRAY WITH AN ABSORPTION AGENT - A method for separating overspray from the cabin exhaust air of coating systems, in particular of painting systems, which is laden with overspray, the overspray is taken up by an air flow and conveyed to an electrostatically operating separating device. There, the bulk at least of the solids is separated from the overspray at at least one separating surface. An electrically conductive material or material mixture is used as a separating agent, which is applied to the at least one separating surface of the separating device and at the operating temperature of the separating device has a wax-like consistency. Also a separating device with such a wax-like material and a system for coating articles. | 02-07-2013 |
20130319822 | SURFACE TREATMENT PLANT FOR MOTOR VEHICLE BODIES - A surface treatment plant for vehicle bodies having a first treatment area which comprises a first conveyor system enabling a vehicle body to be conveyed through the first treatment area, and a second treatment area which includes a second conveyor system enabling the vehicle body to be conveyed through the second treatment area. A transfer device enables the vehicle body to be transferred from the first conveyor system to the second conveyor system. The transfer device includes supports which engage on regions of the vehicle body and at least one is arranged in particular on the highest point of the horizontal and the vehicle body is oriented roof upwards. Also a method for conveying vehicle bodies through a surface treatment plant. | 12-05-2013 |
Patent application number | Description | Published |
20100286276 | Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof - The present invention concerns substituted 1,3-diphenylpropane derivatives, pharmaceutical compositions comprising them and the therapeutic uses thereof, particularly in the field of human and animal health. | 11-11-2010 |
20140309165 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as amino-transferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 10-16-2014 |
20150051145 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 02-19-2015 |
Patent application number | Description | Published |
20100286276 | Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof - The present invention concerns substituted 1,3-diphenylpropane derivatives, pharmaceutical compositions comprising them and the therapeutic uses thereof, particularly in the field of human and animal health. | 11-11-2010 |
20110136888 | Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof - The present invention involves substituted 1,3-diphenylpropane derivatives, pharmaceutical compositions comprising them and the therapeutic uses thereof, in particular in the fields of human and animal health. | 06-09-2011 |
20120252725 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as amino-transferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 10-04-2012 |
Patent application number | Description | Published |
20100106530 | SYSTEM AND METHODS FOR DISTRIBUTED ANALYSIS OF PATIENT RECORDS - A system and associated methods provide healthcare entities with analyzing capabilities for records of a patient population. The analyzing process seeks to find matches between a piece of clinical knowledge introduced to a healthcare entity and data contained in the patient population records. According to one method, a service generates executable code based on the piece of clinical knowledge. Through a communication with the service, the healthcare entity makes a determination as to what extent the clinical knowledge has relevance to a patient population of the healthcare entity. Based on this determination, the healthcare entity receives at least a portion of the executable code. Then, the records of the patient population may be analyzed by the executable code to register matches of the clinical knowledge with data contained within the records. System activity may then be initiated based on the matches registered. Examples of system activity include compiling a contact list of patients and/or healthcare providers associated with specific records where matches occurred, generating a report about the matches registered, and flagging specific records where matches occurred so that care providers may discuss issues surrounding the clinical knowledge with associated patients in a future encounter with the healthcare entity, among others. | 04-29-2010 |
20100106531 | SYSTEM AND METHOD FOR DISTRIBUTED ANALYSIS OF PATIENT RECORDS - A system and associated methods provide healthcare entities with analyzing capabilities for records of a patient population. The analyzing process seeks to find matches between a piece of clinical knowledge introduced to a healthcare entity and data contained in the patient population records. According to one method, a service generates executable code based on the piece of clinical knowledge. Through a communication with the service, the healthcare entity makes a determination as to what extent the clinical knowledge has relevance to a patient population of the healthcare entity. Based on this determination, the healthcare entity receives at least a portion of the executable code. Then, the records of the patient population may be analyzed by the executable code to register matches of the clinical knowledge with data contained within the records. System activity may then be initiated based on the matches registered. Examples of system activity include compiling a contact list of patients and/or healthcare providers associated with specific records where matches occurred, generating a report about the matches registered, and flagging specific records where matches occurred so that care providers may discuss issues surrounding the clinical knowledge with associated patients in a future encounter with the healthcare entity, among others. | 04-29-2010 |